Shares of Biotechnology company Five Prime Therapeutics (NASDAQ: FPRX) have skyrocketed premarket on Wednesday after the company released positive data from its Phase 2 FIGHT trial.
The trial evaluates the combination of Five Prime’s drug, bemarituzumab and chemotherapy in fighting advanced gastric and gastroesophageal cancer.
Five Prime stated that all efficacy endpoints in the trial met “pre-specified statistical significance,” and that bemarituzumab and chemotherapy demonstrated a significant progression-free overall survival benefit.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
“These results bring us one step closer to the first potential targeted therapy for advanced gastric cancer in over a decade,” said Helen Collins, Five Prime’s Executive Vice President and Chief Medical Officer.
The San Francisco based company said that it is the first data to signal that targeted therapy may reduce the risk of disease progression and improve overall survival in gastric cancer.
Five Prime said they will now complete a full review of the data from the trial and work with investigators to share the results at an upcoming medical conference.
Five Primes stock price has jumped an enormous 340% on the news and is priced at $23.47 per share premarket after closing Tuesday at $5.34.
PEOPLE WHO READ THIS ALSO VIEWED:
